Indication

Stage IA2 Cervical Cancer

1 clinical trial

1 product

Clinical trial
Evaluation of Resectable Cervical Carcinoma With PET/MRI
Status: Active (not recruiting), Estimated PCD: 2025-09-30
Product
Gadobutrol